A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma.
about
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A phase I trial of the γ-secre ...... creatic ductal adenocarcinoma.
@en
A phase I trial of the γ-secre ...... creatic ductal adenocarcinoma.
@nl
type
label
A phase I trial of the γ-secre ...... creatic ductal adenocarcinoma.
@en
A phase I trial of the γ-secre ...... creatic ductal adenocarcinoma.
@nl
prefLabel
A phase I trial of the γ-secre ...... creatic ductal adenocarcinoma.
@en
A phase I trial of the γ-secre ...... creatic ductal adenocarcinoma.
@nl
P2093
P2860
P356
P1476
A phase I trial of the γ-secre ...... creatic ductal adenocarcinoma.
@en
P2093
Aarthi Gopinathan
Balaji Venugopal
Bristi Basu
D Alan Anthoney
Daniel Palmer
David Propper
Donna-Michelle Smith
Duncan Jodrell
Hayley Farmer-Hall
Helen Turner
P2860
P2888
P304
P356
10.1038/BJC.2017.495
P407
P577
2018-02-13T00:00:00Z
P6179
1101001178